Press Releases

Date Title and Summary View
Toggle Summary Horizon Technology Finance to Announce Fourth Quarter 2021 Financial Results
FARMINGTON, Conn. , Feb. 15, 2022 /PRNewswire/  --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
View HTML
Toggle Summary Horizon Technology Finance Leads $50 Million Venture Loan Facility to FinTech and InsurTech Innovator, Autonomy
FARMINGTON, Conn. , Jan. 25, 2022 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and...
View HTML
Toggle Summary Horizon Technology Finance Provides Fourth Quarter 2021 Portfolio Update
-Horizon Platform Originates $118 Million of New Loans in Q4, Including $80 Million of New Loans for HRZN - -HRZN Grows Loan Portfolio by $109 Million in 2021 - -Horizon Platform Ends 2021 with Committed Backlog of $153 Million, Including $125 Million in HRZN Commitments - FARMINGTON, Conn. , Jan....
View HTML
Toggle Summary Horizon Technology Finance Leads $30 Million Venture Loan Facility to Leading D2C Custom Furniture Business Interior Define
FARMINGTON, Conn. , Jan. 11, 2022 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and...
View HTML
Toggle Summary Horizon Technology Finance Provides Additional $5 Million Venture Loan to Everstream Analytics
FARMINGTON, Conn. , Nov. 29, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and...
View HTML
Toggle Summary Horizon Technology Finance Announces Monthly Distributions for January, February and March 2022 Totaling $0.30 per Share and Special Distribution for December 2021 of $0.05 per Share
FARMINGTON, Conn. , Oct. 26, 2021 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
View HTML
Toggle Summary Horizon Technology Finance Corporation Announces Third Quarter 2021 Financial Results
- Net Investment Income per Share of $0.40; NAV per Share of $11.63 - - Debt Portfolio Yield of 16.2% - - Declares Regular Monthly Distributions of $0.10 per Share through March 2022 and $0.05 Special Distribution Payable in December 2021 - - Grew Portfolio to Record $452 Million - FARMINGTON,...
View HTML
Toggle Summary Horizon Technology Finance to Announce Third Quarter 2021 Financial Results
FARMINGTON, Conn. , Oct. 12, 2021 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
View HTML
Toggle Summary Horizon Technology Finance Provides Third Quarter 2021 Portfolio Update
- Horizon Platform Originates Record $141 Million of New Loans - - Record $99 Million of Originations for HRZN - - Horizon Platform Committed Backlog of $123 Million; $101 Million in HRZN Commitments - FARMINGTON, Conn. , Oct. 6, 2021 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ:...
View HTML
Toggle Summary Stealth BioTherapeutics Completes a $25 Million Debt Financing with Horizon Technology Finance
BOSTON , Oct. 4, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced completion of a $25 million...
View HTML

Horizon Technology Finance
Dan Trolio
Executive Vice President & CFO
(860) 674-9977
dtrolio@horizontechfinance.com

ICR Group
Garrett Edson
Managing Director
(646) 200-8885
ir@horizontechfinance.com

Horizon Technology Finance
312 Farmington Avenue
Farmington, CT
06032

Jerry Michaud
(860) 676-8659
jmichaud@horizontechfinance.com

Horizon Technology Finance
349 Main Street
Suite 203
Pleasanton, CA
94566

Kevin May
(925) 935-2924
kmay@horizontechfinance.com
Nasdaq SBIA NYSE
HORIZON TECHNOLOGY FINANCE
A Life Sciences & Technology Venture Lending Partner

info@horizontechfinance.com | Privacy Policy | Site Map

Loans made or arranged in California pursuant to a California Financing Law license.

Copyright © 2024 Horizon Technology Finance Management LLC. All rights reserved.

website by DIANA STUTZ DESIGN